FXI iShares China Large-Cap ETF
Mixed Confidence 0.45 Regime Low-vol
Maintain a ‘mixed’ conclusion on FXI. The divergences are driven by three non-price pieces of evidence: Arc #359 indicates ongoing funding dynamics and hedging pressures (30-day net redemptions ≈ -3.6% AUM, institutional short positions ≈ 64.4M shares, DTC ≈ 3.81); Arc #204 still provides positive trickle-down evidence of policy easing (PBoC targeted tools and the implementation of previous PSL/reloan programs); Arc #98 reports that US core CPI remains hot with rising Treasury yields, posing a macro headwind to emerging markets denominated in dollars. All three are recent signals (≤7 days) rather than confirmed or actionable ones, with directions offsetting each other, hence maintaining a mixed view with low-to-medium confidence.
30-day verdict history
| Date | Direction | Confidence | Thesis |
|---|---|---|---|
| 2026-10-15 | Mixed | 0.45 | Maintain a ‘mixed’ conclusion on FXI. The divergences are driven by three non-price pieces of evidence: Arc #359 indicates ongoing funding dynamics and hedging pressures (30-day net redemptions ≈ -3.6% AUM, institutional short positions ≈ 64.4M shares, DTC ≈ 3.81); Arc #204 still provides positive trickle-down evidence of policy easing (PBoC targeted tools and the implementation of previous PSL/reloan programs); Arc #98 reports that US core CPI remains hot with rising Treasury yields, posing a macro headwind to emerging markets denominated in dollars. All three are recent signals (≤7 days) rather than confirmed or actionable ones, with directions offsetting each other, hence maintaining a mixed view with low-to-medium confidence. |
| 2026-10-14 | Mixed | 0.45 | I have revised my conclusion on FXI from bullish to 'Mixed/Neutral', primarily because the dominant bullish signal #204 (china_financial_regulation) has significantly weakened since last time, with a decline in confidence and quantitative evidence indicating continued outflows that cannot alone support high-confidence bullishness. Contrary non-price evidence comes from arcs #359 and #306: 30-day net redemptions of approximately -3.6% AUM, and institutional short positions rising to about 64.4M shares (DTC≈3.81), indicating ongoing fund flows and short-selling pressure; and the downward action in arc #306 is marked as price_in (part of the decline has already been priced in by the market), thus limiting the strength of directional bias. Arc #98 remains contested, and given the current REGIME as a mixed risk profile, I maintain a mixed judgment with low to medium confidence. |
| 2026-10-13 | Bullish lean | 0.64 | Maintain a lean positive view on FXI in the medium term. The primary reason is the quantifiable policy evidence provided by arc #204: the People's Bank of China (PBOC) has reduced the interest rate on PSL and expanded rediscounting (‘increase quota + increase ratio’, with an additional 500 billion yuan in rediscounting), which directly improves targeted financing transmission and strengthens bullish fundamentals. The opposing view comes from structural liquidity signals indicated by arcs #359 and #306 – net redemptions remain negative over the past 30 days (≈-3.62% AUM) with short positions at approximately 64.4 million shares, DTC ≈ 3.81, and arc #306 is marked as partially ‘price_in’, indicating that some downside risk has been absorbed by the market; arc #98 (Fed/macro) remains contested with no evidence of foreign exchange intervention, so overall confidence is moderately positive. |
| 2026-10-12 | Bullish lean | 0.64 | Tilting towards a medium-term bullish stance (lean_positive) due to the new and quantifiable positive policy evidence provided by arc#204 (china_financial_regulation): the People's Bank of China/relevant departments have reduced the PSL interest rate and expanded the relending facilities ('increase quota + increase ratio', with an additional 500 billion yuan in relending). This directly improves targeted financing and liquidity, reinforcing the fundamental transmission chain for FXI. However, opposing forces still exist and should not be overlooked—arc#359 and arc#306 reports indicate net redemptions over the past 30 days (≈-3.62% AUM) and high short positions (short shares ≈64.4M, DTC ≈3.8), with part of the price decline in arc#306 already factored into prices (price_in flagged). Therefore, while policy evidence makes a bullish stance the preferred direction, confidence is constrained by funding conditions/short position pressures. If this policy evidence is withdrawn or funding conditions deteriorate further (excluding directional changes such as large net outflows or rapid short covering), a re-evaluation will be necessary. |
| 2026-10-11 | Bearish lean | 0.61 | Maintain a lean-negative view on FXI in the medium term. The non-price evidence driving this direction mainly comes from Arc #359 (china_financial_regulation trigger): net outflows of approximately -3.7% AUM over the past 30 days and high short positions (short shares ≈62.3M, days-to-cover ≈3.6) indicate structural downward pressure from fund flows and short-selling forces; Arc #306's trade/tariff concerns also support the bearish logic but is less relevant due to its age (days_since_event 26.7). The main argument against the bullish view comes from Arc #204 (china_financial_regulation bull case), which proposes targeted monetary/policy support as a non-price factor, but this arc is marked with price_in (price_in_excess flagged=True) in the bullish direction, so it should be approached cautiously and its impact correspondingly reduced. In summary, based on Arc #359's fund flow and position evidence, maintain a lean-negative view while confidence is dampened by already priced-in and outdated counterarguments. |
| 2026-10-10 | Bearish lean | 0.56 | Conclusion: Maintain a lean-negative stance on FXI for the next 1-3 months. The non-price evidence driving this conclusion, primarily from Arc #359, indicates substantial fund outflows in recent times (net redemptions of approximately -3.71% AUM over 30 days) and persistent high short positions (62,269,109 shares, days-to-cover ≈ 3.57), which create structural downward pressure for the medium term. Although Arc #204 provides a basis for bullish sentiment with targeted monetary tools from the central bank (PSL rate cut by 25bp, expansion of rediscounting quotas and targeted lending facilities), there is currently insufficient evidence of transmission to credit/lending to fully offset the funding and short pressure; additionally, part of the rebound indicated in Arc #306 has been price_in (flagged=True), so caution is warranted regarding confidence in a recovery. |
| 2026-10-09 | Bearish lean | 0.56 | Conclusion: Maintain a lean_negative stance on FXI for the 1-3 month outlook. The primary driver of this directional change is arc #359 (ecb_eurozone_rate_cycle), which provides non-price evidence indicating substantial outflows and structural short positions, with net redemptions of approximately -3.71% AUM over 30 days and persistent high levels of short positions (62.27M shares, days-to-cover ≈ 3.57). Although arc #204 (central bank targeted monetary tools) still forms the basis for a policy bullish stance, empirical evidence of funding and credit transmission effects has not yet been strong enough to offset outflows and short pressure; additionally, arc #306's price_in signal suggests that some intermediate-to-long-term rebounds have already been factored in. Therefore, only a mild negative position is recommended with controlled position sizes (non-trend-following counter-market positions driven by the specific funding/position dynamics of arc #359). |
| 2026-10-08 | Bullish lean | 0.52 | Comprehensive Analysis with Arc #204 as the Main Non-Price Driver: The structural monetary tools introduced by the People's Bank of China (PSL rate cut, expanded and increased ) form a causal chain of 'cost reduction -> targeted credit recovery -> alleviation of financial intermediary pressure', supporting a positive bias for the medium-term outlook on FXI. Contrary evidence comes from Arc #98 and Arc #104 reports indicating funding and structural pressures — net redemptions have been negative over the past 30 days, with continuously accumulating short positions, and Arc #104 notes price_in (indicating that some positive factors are already reflected in the market). Therefore, only a moderate bias is advisable, with controlled leverage and position size. |
| 2026-10-07 | Bullish lean | 0.58 | Maintain a positive bias. The main driver is Arc #204: On September 29, the People's Bank of China reduced the PSL interest rate by 25bp and expanded /, forming a clear non-price causal chain (policy-driven reduction in funding costs -> improved targeted credit supply -> substantive support for financial sector). However, there is also substantial evidence of friction: Arc #98/Arc #104 reports negative liquidity signals and high short positions that have recently accumulated significantly over the past 30 days. Additionally, Arc #204 itself is marked as price_in (indicating that positive news has already been partially priced in), thus confidence is moderately adjusted downward and it is advised to control.) |
| 2026-10-06 | Bullish lean | 0.62 | Based on the Arc#204 report, the People's Bank of China formed a quantifiable causal chain through clear policy intervention by lowering the PSL rate and expanding /reverse repos on September 29 (policy-driven funding cost reduction -> improved targeted credit supply -> substantive support for the financial sector), which is the main driver behind the shift from bearish to bullish sentiment. However, evidence of liquidity conditions and positions still pose friction to the bulls: multiple days of net redemptions, high short interest that has rapidly accumulated in recent periods (see Arc#98 / Arc#104 fund_flow and short_interest), and Arc#204 itself noting price_in (partially reflecting the decline). Therefore, confidence is ≥0.60. Considering these conflicting non-price indicators, it is advised to take a slightly bullish stance in the short to medium term (1-3 months) while controlling position size and event risk exposure. |
| 2026-10-05 | Bearish lean | 0.48 | Maintain a bearish stance. Mainly based on non-price quantitative evidence: weak credit as indicated by the decline in social financing and loan growth in arc #204, and net redemptions and visible accumulation of short positions highlighted by arcs #98 and #306, which provide substantial support for the FXI's medium-term downward trend. It is important to note that both independent bearish arcs (#204 and #306) are somewhat outdated (days_since_event >14), with some declines already marked in arc #98 as price_in (already factored in). Therefore, confidence should be kept at a low-to-medium level and caution maintained. A new and verifiable non-price confirmation (such as PBoC/credit or BoJ actual policy actions) could warrant an increase or shift in position. |
| 2026-10-04 | Bearish lean | 0.45 | Maintain a bearish stance. Mainly based on the non-price evidence from arcs #306 and #98: net redemptions of approximately -$132M (≈-3.37% AUM) for FXI starting from 2026-09-25, and visible short positions totaling 62,269,109 shares (DTC=3.57), which constitute substantial support for a medium-term downward trend at the level of funds and positions. It should be noted that the event evidence from arc #306 is somewhat outdated (days_since_event>14), with price levels marked as price_in, suggesting some of the decline may already be priced in; arc #98 is decaying/contested, while arc #104 remains nascent bullish, thus confidence has been lowered to a medium-low level. |
| 2026-10-03 | Bearish lean | 0.50 | Overall bias negative: driven primarily by non-price evidence - Arc#306 and Arc#98 reports show net redemptions of approximately -$132M (≈-3.37% AUM) starting from 2026-09-25, along with visible short positions of 62,269,109 shares (DTC=3.57), providing independent downward momentum at the fund/position level and supporting a medium-term bearish outlook. Note that weakness has already been flagged on the price side, and Arc#104 (related to BoJ) remains nascent with no independent non-price confirmation yet, indicating that some of the downside is already priced in and confidence is moderately dampened. Given the mix of old and new information with no recent clear central bank/policy confirmation, maintain a medium-bearish stance but do not increase positions. |
| 2026-10-02 | Bearish lean | 0.50 | Maintain a moderately bearish stance on FXI: fundamental and position evidence not related to prices dominate the direction. According to data from Arc #204 (China Financial Regulation), weak social financing/long-term loans in August indicate pressure on bank lending to the real economy, which may cap valuations weighted towards financials and state-owned enterprises; meanwhile, the real net redemptions reported by Arc #306 (-$132M / -3.37% AUM over the past 30 days) and visible short positions (62.27 million shares, DTC=3.57) provide independent fund/position evidence supporting a moderately bearish outlook in the medium term. Offset factors include Arc #104 (BoJ Yen Normalization) still being nascent with no additional non-price confirmation signals; also note that price_in for Arcs #204 and #306 has been flagged, indicating that some information is already reflected in prices, hence maintaining a moderately bearish stance rather than high-confidence one-sided positions. |
| 2026-10-01 | Bearish lean | 0.48 | We have a moderately bearish view on FXI: fundamental evidence excluding price factors points to pressure – the People's Bank of China's disclosure of weak August social financing/loans (Arc #204) indicates government bond substitution for social financing, which may limit bank lending and earnings in financial sectors, thereby compressing the valuation ceiling of FXI; meanwhile, real net redemptions and increased short positions have emerged in liquidity dynamics (Arc #306), providing independent bearish evidence that has shifted this arc from contested to short, thus driving the directional change. Two points of caution are necessary: these impacts have already been partially priced into the market (price_in annotation), and the BoJ/yen-related bullish transmission remains an unverified nascent argument (Arc #104), so we provide a bearish bias rather than a high-confidence one-sided position. |
| 2026-09-30 | Mixed | 0.44 | Maintain a mixed view (mixed) because of divergent information and the lack of a single non-price piece of evidence that could decisively lock in a direction. The driving non-price evidence comes from Arc #204 (the People's Bank of China's disclosure of August social financing/loan data): significant substitution by government bond net financing for social financing suggests inadequate bank lending to entities → suppressing bank and financial sector earnings and limiting the valuation ceiling for FXI; however, this arc is decaying and marked as price_in, indicating that some of its impact has already been priced in, reducing the operability of establishing a one-sided position. Arc #104 (BoJ yen normalization) remains an unverified potential bullish transmission, while Arc #98/306 indicates net outflows over 30 days, low IV, and high bullish positions, making the situation complex; therefore, maintain a mixed view in the short term without tilting significantly toward any position. |
| 2026-09-29 | Mixed | 0.46 | Maintaining a mixed view continues to be the stance. The primary driver is Arc #204 (PBOC's disclosure on August credit/S ): the non-price chain is clear - government bond net financing significantly replaced social financing in August, suggesting insufficient bank lending to the real economy, which dampens bank/financial sector earnings and imposes a downside constraint on FXI. However, this arc is decaying and marked as price_in, indicating that some of the impact has already been priced into the market, reducing the operability of one-sided positions. Arc #104 (BoJ normalization) provides potential bullish transmission (JPY strong -> USD weak -> risk appetite/currency benefits for FXI), but it is nascent/unconfirmed. Arcs #214 and others related to trade reflect more priced-in risks, thus the evidence direction is mixed with no fresh non-price evidence to support a one-sided position. |
| 2026-09-27 | Mixed | 0.44 | Continue to maintain a mixed view as there is no single arc providing sufficient and up-to-date non-price causal chains to support a one-sided position. Arc #204 (PBOC credit and social financing weakness in August) remains the most direct non-price evidence – its transmission path being weak credit → pressure on bank spreads and intermediary business → constrained financial sector profitability → downward constraint on FXI, but this arc is decaying and its conclusion is still contested with limited support. Trade-related arcs (#306, #214) mainly reflect price reactions (already marked as price_in), lacking quantifiable counterpart transmission; Arc #104 (BoJ normalization) proposes a reasonable bullish transmission chain but remains nascent and unconfirmed, hence does not alter the mixed conclusion. |
| 2026-09-26 | Mixed | 0.44 | Maintain a mixed view. Arc#204 (China Financial Regulation) still provides the most direct non-price evidence: the PBOC's August loan and social financing weakness will suppress financial sector earnings through bank spreads and intermediary business, thereby exerting downward pressure on FXI; however, this evidence is not sufficient to unilaterally determine a position. Other major arcs (such as Arc#98 Fed Cycle, Arc#306 US-EU Tariffs/Arc#214 Trump Tariffs) lack quantifiable transmission chains, and some trade arcs have been marked as price_in, reducing additional confidence. In summary: no new, clear non-price triggers have shifted the view to a one-sided long or short position; hence, continue with a mixed stance. |
| 2026-09-25 | Mixed | 0.44 | Maintain a mixed view. The non-price evidence provided by Arc #204 (China Financial Regulation) – the PBOC's August loan and significantly weakening – remains the most direct downward force on the financial sector and consequently on FXI, but this arc is marked as price_in, indicating that some of the impact has already been reflected in prices/derivatives markets. Other major arcs (#98 Fed Cycle, #306 US-EU Tariff Dispute) lack quantifiable counterpart transmission and are mostly weak or outdated signals, failing to form a unidirectional bullish or bearish non-price evidence chain. In summary: the non-price evidence is offset by price/derivatives signals that have been |
| 2026-09-24 | Mixed | 0.45 | Maintain a mixed view. Arc #204 (China Financial Regulation) provides non-price evidence – the PBoC's August loan and social financing growth was notably weak, which remains the most compelling downside driver along the transmission chain of 'credit weakness -> financial sector profit constraints -> pressure on FXI'. However, the price_in for this arc has already been marked (partially reflected in prices), so it cannot be raised to high confidence. The Bank of Japan normalization (Arc #104) and recent Fed/macroeconomic comments (Arc #98) lack quantifiable counterparties to support a one-sided bullish or bearish stance, and multiple political/tariff narratives are already priced-in (Arcs #204/306/214 marked as priced-in). The overall context is a mix of offsetting evidence and incremental uncertainty, so continue with a mixed view at low-to-moderate confidence. |
| 2026-09-23 | Mixed | 0.45 | Maintain a mixed view. The non-price evidence from arc #204 (china_financial_regulation) is most bearish: PBoC's August loan and social financing growth was notably weak, providing substantial downside pressure through the transmission chain of 'credit weakness -> bank/brokerage earnings pressure -> weight sectors in FXI under pressure'. The hedging comes from the yen/policy narrative proposed by arc #104 (yen normalization), but this arc lacks quantifiable counterpart evidence (Japan's core CPI remains cold, with no significant rise in rates/swaps observed), making it unable to independently confirm a bullish stance. Additionally, note that several tariff/political narratives (arcs #306 and #214) have been partially priced into the market through price_in, and most arcs are either decaying or nascent, thus maintaining a mixed view with low-to-medium confidence overall. |
| 2026-09-21 | Mixed | 0.45 | Maintain mixed. Arc #204 (china_financial_regulation) provides clear non-price downside evidence: August RMB loans and significantly below expectations, forming a substantial downside based on the transmission chain of 'credit weakness -> pressure on bank/broker profit elasticity -> pressure on weight sectors in FXI'; but Arc #104 (Yen normalization) still proposes |
| 2026-09-20 | Mixed | 0.45 | Maintain a mixed stance: Arc #204 (china_financial_regulation) provided clear non-price negative evidence in this update—RMB loans and social financing growth significantly undershot expectations in August, forming a substantial downward basis through the transmission chain of 'credit weakness -> pressure on bank/broker profit elasticity -> pressure on weighty sectors of FXI'; however, Arc #104 (BOJ normalization) still suggests possible positive medium-term implications (yen recovery -> dollar decline -> relatively favorable for Chinese assets). The two offset each other. Additionally, several tariff/detachment narratives (such as #214/#306/#247) have been partially priced into prices in the short term, and most arcs remain decaying or contested, thus no high-confidence trading signal can be confirmed; based on this balance of non-price evidence and the already-priced components, maintain a low-to-medium confidence level. |
| 2026-09-19 | Mixed | 0.45 | Maintain mixed. Arc#204 (china_financial_regulation) provided a new, non-price piece of evidence in this update – August RMB loans and significantly below expectations, which can be expressed as weak credit -> pressure on bank/broker profit elasticity -> negative transmission to the weight of FXI, constituting clear negative foundational evidence. In contrast, Arc#104 (Yen Normalization) provides a positive medium-term transmission (BoJ hawkish -> yen stabilization -> easing USD impact on emerging markets), and several tariff/detachment-related arcs have been partially |
| 2026-09-18 | Mixed | 0.45 | Conclusion is mixed: Arc #204 (china_financial_regulation) provides a new, price-agnostic quantitative evidence in this update – August social financing and RMB loans significantly below expectations, constituting a downward transmission from weak credit to pressure on bank/brokerage earnings flexibility via the FXI weight sectors; this represents substantial new information that changes the previous bullish assessment. In contrast, Arc #104 (BoJ normalization) still provides a quantifiable positive chain of evidence (BoJ hawkish -> yen stabilization -> potential relief of emerging market capital outflows), but with limited evidentiary strength and serving as a single support point. Other major narratives (such as Arcs #214/#306/#247 on tariffs/de-coupling issues) are mostly marked as price_in or lack corresponding non-price evidence in this window, and the current REGIME (rates_inflation_risk_off) along with accumulated short positions limits high-confidence judgments, thus offsetting weights and preventing overconfidence. |
| 2026-09-17 | Bullish lean | 0.62 | Maintain a positive view on FXI, primarily based on quantifiable non-price evidence from arc#104 (BoJ clearly hawkish/policy normalization) – including the central bank stance shift, an increase in the subscription multiple for 30-year JGB auctions to 3.79, and net systemic liquidity inflows, which form a reasonable transmission chain (yen stabilization -> mitigating dollar outflows from emerging markets -> supporting the Chinese market). Meanwhile, note that most trade/regulatory narratives related to China (arcs#214/#247/#306, etc.) have already seen significant “price-in” in recent price movements (flagged), but lack corresponding non-price quantifiable evidence. Therefore, they cannot be considered as standalone reversal reasons; additionally, given the current REGIME with rate/inflation-driven risk aversion (rates_inflation_risk_off), there is a need for moderate caution at high confidence levels and acknowledging that some of the gains have already been priced in by the market. |
| 2026-09-16 | Bullish lean | 0.60 | Driven by Non-Price Evidence: Arc #204 (China Financial Regulation) indicates that the 3000 billion yuan special treasury bonds from the Ministry of Finance and the 5000 billion yuan, 89-day repurchase agreement from the PBOC constitute a quantifiable liquidity/regulatory relief, forming a neutral to positive foundation for the Chinese large-cap market (FXI). Arc #104 (BoJ Yen Normalization) represents a recent non-price event (the BoJ clearly tilting hawkish), providing an additional pro-cyclical transmission path. Together, they support a medium-term bullish outlook. However, it is important to note the short-term overcrowding and risk repricing: multiple arcs show rapid accumulation of shorts, with some narratives (Arc #214, #247) partially absorbed by prices. The current REGIME is relatively tight/risk-dispersed (VIX term ratio increased), thus confidence is moderately constrained at a medium level. |
| 2026-09-15 | Bullish lean | 0.40 | Maintain a positive stance on FXI in the medium term, primarily based on the non-price transmission chain of arc#204 (China Financial Regulation): the Ministry of Finance's RMB 30 billion special treasury bonds plus the People's Bank of China's RMB 50 billion 89-day repo constitute quantifiable liquidity/regulatory relief, theoretically benefiting financial sectors and risk appetite. Hedge and downside risks come from independent non-price evidence from arc#98 (Fed 2026 Rate Cycle) – with market interest rate hike probabilities predicted to rise to 0.83 and recent core CPI exceeding expectations, posing real pressure on Chinese risk assets; additionally, multiple arcs indicate that some of the gains have been reflected in prices and bearish sentiment is increasing, warranting caution regarding 'priced-in/reversal' risks. Given the current convergence risk environment (REGIME) centered around interest rates/inflation, I do not increase confidence, hence maintaining a slight positive bias (lean_positive) with confidence reduced to 0.40. |
| 2026-09-14 | Bullish lean | 0.45 | Maintain a positive medium-term stance on FXI, primarily based on the non-price transmission chain #204: the quantifiable liquidity/regulatory relief path from the Ministry of Finance's 30 billion yuan special bonds and the People's Bank of China's 50 billion yuan 89-day repo buyback constitutes theoretical support for the financial sector. On the contrary, arc #98 (the Fed interest rate cycle) provides independent non-price evidence—predicting a market probability of 0.83 for rate hikes with recent core CPI exceeding expectations—which represents a genuine downside risk to Chinese risk assets; and the quantified snapshot of arc #204 itself shows accumulation in redemptions/short positions and low IV, indicating that the positive factors have been partially reflected and there is vulnerability. Therefore, while still positive, confidence is reduced by the quantitative contradictions from arcs #98 and #204, so we do not raise it to high confidence. |